Privat-docent thesis
OA Policy
English

Liver transplantation for the treatment of hepatocellular carcinoma

Contributors

Toso, Christian

Defense date

2010

Abstract

Liver transplantation is the best treatment option for selected patients with non-resectable hepatocellular carcinoma (HCC). In many centers, patient selection is currently performed according to Milan criteria and allowing transplantation for patients with a single HCC ≤5cm or up to 3 HCCs ≤3cm. The present thesis demonstrates that patients with more advanced HCCs, with total tumor volume ≤115cm3 and alpha-fetoprotein ≤400ng/ml, can also benefit from liver transplantation and have similarly good post-transplant outcomes. Another way of allowing transplantation to patients with more advanced HCC, is to downstage HCCs prior to listing. This option is also discussed. Adjuvant post-transplant management should be performed with the use of sirolimus, an immunosuppression drug with anti-cancer properties. This drug has an appropriate side-effect profile and improves post transplantation survival in patients with HCC. Such strategies will help including more patients for transplantation, with maintained good post-transplant survivals.

Keywords

  • Transplantation
  • Liver
  • Hepatocellular carcinoma
  • Sirolimus

Citation (ISO format)

TOSO, Christian. Liver transplantation for the treatment of hepatocellular carcinoma. Privat-docent Thesis, 2010. doi: 10.13097/archive-ouverte/unige:12935

Main files (1)

Thesis

Identifiers

724views
950downloads

Technical informations

Creation

17/12/2010 17:38:00

First validation

17/12/2010 17:38:00

Update

14/10/2025 08:17:04

Status update

14/03/2023 16:10:38

Last indexation

04/02/2026 14:46:04
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated